Walgreens Implements Deep Restructuring Following Private Buyout

Since its acquisition by the private equity firm Sycamore Partners was finalized in the summer of 2025, Walgreens has embarked on an aggressive corporate transformation. The move away from public markets is now being followed by sweeping operational changes, including significant store closures and workforce reductions, as the company seeks a new path forward under private ownership.

A New Structure for a New Era

A pivotal moment in this transition was the company’s delisting from the Nasdaq on August 28, 2025. Former shareholders received $11.45 per share, concluding Walgreens’ chapter as a publicly traded entity. Operating as a private company has freed its leadership from the quarterly reporting cycle and dividend obligations, allowing a focus on long-term restructuring away from the spotlight of Wall Street expectations.

Under the leadership of CEO Mike Motz, the organization has been decentralized into five distinct business units: the core Walgreens Retail Pharmacy, Boots Group, VillageMD, CareCentrix, and Shields Health Solutions. This structural shift is designed to enhance operational agility, enabling each segment to respond more effectively to specific market challenges while corporate management works to stabilize the overall cost base.

Operational Efficiency Takes Center Stage

The pursuit of leaner operations is most visible in two key areas: its physical footprint and its workforce. Data indicates a strategic reduction of the store network from approximately 8,500 locations to about 8,000. This consolidation effort is a central component of a turnaround strategy focused on exiting unprofitable locations and optimizing the remaining pharmacy network.

Should investors sell immediately? Or is it worth buying Walgreens?

Parallel to the store closures, the employee headcount has been substantially reduced. The workforce has been trimmed from 220,000 to roughly 211,000 employees. These job cuts are part of a broader cost-saving initiative. By the end of 2025, reports indicated that management had also eliminated holiday pay premiums for certain hourly positions in a bid to support operational margins.

Navigating a Competitive Landscape

The radical restructuring is largely a response to intense market pressures. The core pharmacy business faces significant challenges from digital competitors and evolving consumer habits in the healthcare sector. The company’s strategy now bets that a more decentralized, efficient, and privately held structure will provide the flexibility needed to compete.

The coming months will test whether this new approach can successfully reposition Walgreens against growing online competition. The consolidation of its retail network remains the primary tool for attempting to restore profitability in a difficult market environment. The success of this private equity-led “reset” will ultimately be measured by the financial resilience of its five newly independent divisions.